{{Rsnum
|rsid=17420802
|Chromosome=7
|Orientation=minus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=PMS2
|position=5977709
|Gene_s=PMS2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 33.8 | 55.4 | 10.8
| HCB | 11.9 | 35.7 | 52.4
| JPT | 0.0 | 32.6 | 67.4
| YRI | 27.0 | 63.5 | 9.5
| ASW | 0.0 | 0.0 | 0.0
| CHB | 11.9 | 35.7 | 52.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

{{ClinVar
|rsid=17420802
|Reversed=1
|FwdREF=A
|FwdALT=G
|REF=T
|ALT=C
|RSPOS=6017340
|CHROM=7
|dbSNPBuildID=123
|SSR=1
|SAO=1
|VP=0x050068000000070102100100
|GENEINFO=PMS2:5395
|GENE_NAME=PMS2
|GENE_ID=5395
|WGT=0
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000007.13:g.6017340T>C
|CLNSRC=Emory University; InSiGHT
|CLNORIGIN=1
|CLNSIG=2
|CLNDBN=Lynch syndrome; AllHighlyPenetrant
|Disease=Lynch syndrome; AllHighlyPenetrant
|Tags=RV;PM;PMC;VLD;G5A;G5;GNO;OTHERKG;LSD
|CLNACC=RCV000030368.2; RCV000079108.1
|CLNDSDB=GeneReviews:MedGen:SNOMED_CT; MedGen
|CLNDSDBID=NBK1211:C0009405:315058005; CN169374
|CLNSRCID=4268; c.2324A>G
}}

{{PMID|17253}} [Scientific basis for production of erythrocyte diagnosticums].

{{PMID|10479499}} Mutational analysis of the PMS2 gene in sporadic endometrial cancers with microsatellite instability.

{{PMID|14756672}} Hereditary non-polyposis colorectal cancer and the role of hPMS2 and hEXO1 mutations.

{{PMID|19526325}} Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.

{{PMID|20186688}} Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of Lynch syndrome patients.

{{PMID|20205264}} Clinical analysis of PMS2: mutation detection and avoidance of pseudogenes.

{{on chip | 23andMe v3}}